ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31

Altimmune, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026

$2.23+0.03 (+1.36%)

Close on Oct 19, 2026

Market cap: $413.54M
P/E (TTM): –
Dividend yield: –

Altimmune, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Cash & Equivalents	44	37	135	111	190	116	9.00	34	12	2.88	4.64	19	10	13	11	12	2.67
Short-Term Investments	230	95	63	74	–	100	28	–	–	67	0	–	–	–	–	–	–
Cash & Short-Term Investments	273	132	198	185	190	216	37	34	12	221	4.64	19	10	13	11	12	2.67
Receivables	–	–	–	–	–	–	–	–	–	–	–	0.40	3.60	–	4.87	5.37	–
Prepaid Expenses & Other	2.96	2.20	6.92	5.36	7.95	1.93	0.47	0.55	0.99	0.42	0.18	0.20	0.23	0.55	0.83	1.35	–
Total Current Assets	278	137	210	193	204	230	39	39	23	4.49	17	19	14	20	20	24	–
Property, Plant & Equipment	0.31	0.41	0.65	1.08	1.45	1.06	1.10	1.34	0.60	0.18	0.23	0.33	0.39	0.48	0.79	1.18	–
Gross Property, Plant & Equipment	2.64	2.63	2.63	2.58	3.50	2.66	2.45	2.45	1.55	1.08	2.09	2.51	2.44	2.39	2.40	–	–
Accumulated Depreciation	-2.33	-2.21	-1.98	-1.50	-2.05	-1.60	-1.35	-1.11	-0.95	-0.91	-1.86	-2.19	-2.05	-1.91	-1.61	–	–
Operating Lease Right-of-Use Assets	1.43	1.64	0.36	0.60	0.80	0.90	0.70	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	0	0	–	19	22	2.35	2.35	2.35	2.35	2.35	–
Intangible Assets	–	0	0	12	12	13	13	14	39	15	–	–	–	–	–	–	–
Other Long-Term Assets	1.43	1.64	0.36	0.62	0.87	0.98	0.13	0.18	0.24	0.02	0.05	0.05	0.07	0.11	0.05	–	–
Total Assets	280	139	211	207	219	245	54	55	63	38	20	22	17	23	23	27	–
Accounts Payable	2.72	0.21	2.07	4.80	2.03	0.61	0.02	0.37	0.13	2.01	0.52	0.39	1.13	1.70	1.45	3.13	–
Accrued Expenses	–	–	–	–	–	11	3.90	4.08	3.66	2.97	–	–	–	–	–	–	–
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	1.09	1.33	–	–	–
Current Portion of Long-Term Debt	–	–	–	–	–	–	–	–	–	–	0	0.75	1.00	0.75	–	–	–
Current Debt	–	–	–	–	–	–	–	–	–	–	0	0.75	2.09	2.08	–	–	–
Current Portion of Leases	0.26	0.28	0.50	0.45	0.41	0.36	0.26	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	–	–	–	–	–	–	–	3.16	0	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	0.02	0.06	0.02	0.02	0.02	–	–	–	–	–	–	–
Other Current Liabilities	–	–	–	–	–	–	–	–	–	0.01	0.01	0.07	–	–	–	–	–
Total Current Liabilities	15	10	12	17	18	12	3.92	4.53	3.84	5.47	2.18	2.58	6.80	7.49	4.62	6.16	–
Long-Term Debt	34	–	–	4.58	1.45	1.83	1.86	1.85	–	–	–	–	0.73	1.70	–	–	–
Long-Term Leases	1.15	1.40	0.18	0.67	1.12	1.47	1.48	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.40	1.68	0.67	1.12	1.54	1.82	1.74	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	–	–	–	–	–	–	–	0.06	5.94	0.44	0.38	0.32	0	–	–	–	–
Other Long-Term Liabilities	5.75	5.33	0.04	0.06	0.08	0.11	0.13	0.14	0.16	0.44	0.43	0.49	0.59	0.58	0.45	–	–
Total Liabilities	55	16	17	22	20	19	8.54	6.44	14	6.19	3.21	3.70	9.80	11	6.95	15	–
Total Debt	34	–	–	4.58	1.45	1.83	1.86	1.85	–	–	0	0.75	2.82	3.78	–	–	–
Common Stock	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.00	0.00	0.00	–
Additional Paid-In Capital	879	690	665	568	497	417	188	170	122	71	240	239	218	210	209	201	–
Retained Earnings	-649	-561	-466	-378	-293	-186	-137	-117	-78	-31	-224	-220	-210	-199	-194	-190	–
Comprehensive Income & Other	-4.93	-4.97	-5.00	-5.23	-5.04	-5.04	-5.02	-5.04	-4.58	-7.57	0	-0.23	–	–	–	–	–
Shareholders' Equity	225	124	194	185	199	226	46	48	39	32	43	18	7.34	12	16	12	3.15
Total Equity	225	124	194	185	199	226	46	48	39	32	43	18	7.34	12	16	12	3.15
Total Liabilities & Equity	280	139	211	207	219	245	54	55	63	38	20	22	17	23	23	27	–
Shares Outstanding(shares)	111	72	71	49	41	37	15	9.08	0.61	0.23	0.23	0.23	0.19	0.17	0.17	0.17	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: –
Operating margin: -244451.2%
Net margin: -223804.9%
Return on equity, FY2025: -50.6%

Financial strength

Current ratio: 26.78
Debt to equity: 0.07
Debt to assets: 6.6%
Cash to current liabilities: 504.0%

Valuation

P/E ratio: –
Price to sales: 10086.33
Price to book: 0.87
Dividend yield: –